
Molina Healthcare (MOH) Stock Forecast & Price Target
Molina Healthcare (MOH) Analyst Ratings
Bulls say
Molina Healthcare demonstrated strong performance in its Medicare segment, with membership and revenue exceeding expectations, and a managed care ratio (MCR) of 90.0% reflecting improved utilization in acute populations. The Medicaid segment also showed resilience, with an MCR of 91.3% indicating year-over-year and sequential increases due to higher utilization trends among new and renewing members. Additionally, the Marketplace segment experienced significant utilization growth, with a marked increase in medical loss ratio (MLR), underscoring Molina's robust operational performance across its healthcare divisions.
Bears say
Molina Healthcare is facing significant headwinds, with a materially worsening outlook for its 2025/2026 marketplace trends, highlighted by deteriorating data that affects its profitability. The company experienced elevated medical cost pressures across all segments, leading to lowered fiscal year 2025 adjusted EPS estimates to $19.02, down from previous forecasts, primarily driven by Medicaid and Marketplace challenges. As a result, analysts have downgraded their expectations for the company's financial performance, reflecting increased concerns surrounding risk pricing and market shrinkage.
This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Molina Healthcare (MOH) Analyst Forecast & Price Prediction
Start investing in Molina Healthcare (MOH)
Order type
Buy in
Order amount
Est. shares
0 shares